NCT02830906View on ClinicalTrials.gov

Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and Vomiting

PHASE3CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

March 31, 2015

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

ramosetron

intravenous ramosetron 0.3 mg before spinal anesthesia and intrathecal morphine

DRUG

Ondansetron

intravenous ondansetron 8 mg before spinal anesthesia and intrathecal morphine

All Listed Sponsors
lead

Thammasat University

OTHER

NCT02830906 - Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and Vomiting | Biotech Hunter | Biotech Hunter